EN | TR
E-ISSN: 3061-9947
Our Preference for Central Venous Intervention in Patients with Haematologic Malignancies Following Intensive Care Unit
PDF
Cite
Share
Request
Original Article
VOLUME: 51 ISSUE: 3
P: 424-428
2018

Our Preference for Central Venous Intervention in Patients with Haematologic Malignancies Following Intensive Care Unit

Acta Haematol Oncol Turc 2018;51(3):424-428
DOI: 10.5505/aot.2018.28247
Süheyla Ünver 1
Arif Timuroğlu 1
Saadet Menteş 1
Sinem Gevenkiriş 1
Tuğba Aşkın 1
1. Doctor Abdurrahman Yurtaslan Ankara Oncology Training And Research Hospital, Ankara, Turkey
2.
No information available.
No information available
Received Date: 2018-09-08T09:00:47
Accepted Date: 2018-12-28T11:04:37
PDF
Cite
Share
Request

Abstract

INTRODUCTION

Intravenous access in cancer patients is a matter of vital importance. In particular, central venous pressure monitoring, intravenous chemotherapy, multiple antimicrobial treatment, laboratory review of blood sample, long-term nutrition, blood and blood product transfusion as a convenience for such operations are often needed. However, in this group of patients, the central venous catheterization attempt involves a serious complication risk. Catheter-related infections and bleeding problems are a major problem in this group of patients. The decision and management of the central venous catheter is important for patients with haematological malignancies. In this study, we aimed to investigate the use of Central venous catheter interventions in hematologic malignancies patients who have followed anaesthesia intensive care unit in the last year and retrospectively in terms of the complication rate of our choice in the region.

METHODS

In one year, 40 patients with haematological malignancies with a central venous catheter were retrospectively evaluated. The patients were examined in terms of location, bleeding, catheter infection and the day of the catheterization. The data were analysed with SPSS 24.0 version on a personal computer.

RESULTS

16 of the implanted catheters were preferred as internal jugular vein/subclavian vein (40%) and 24 as femoral vein (60%). Three of the implanted catheters were associated with catheter infection, the placement of these catheters was a non-femoral attempt. A patient with a non-femoral procedure had bleeding complication. The mean duration of the femoral catheters was 5.8 days and the mean duration of the catheters placed from the internal jugular vein/subclavian vein was 9.3 days.

DISCUSSION AND CONCLUSION

In patients with hematologic malignancy and intensive care indications, we recommend that femoral catheterization be safely chosen in terms of infection if the required asepsis rules are followed, and subclavian or internal juguler vene should be recommended when appropriate conditions are established for haemostasis.